Anna Huber
Affiliations: | University of Oxford, Oxford, United Kingdom |
Area:
dopamine; reinforcement learning; animal models; mental disorder; fast-scan cyclic voltammetryGoogle:
"Anna Huber"Mean distance: (not calculated yet)
Parents
Sign in to add mentorElizabeth Tunbridge | grad student | Oxford | |
Mark E. Walton | grad student | Oxford |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Panayi MC, Boerner T, Jahans-Price T, et al. (2022) Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience. Molecular Psychiatry |
Korn C, Akam T, Jensen KHR, et al. (2021) Distinct roles for dopamine clearance mechanisms in regulating behavioral flexibility. Molecular Psychiatry |
McHugh SB, Barkus C, Huber A, et al. (2014) Aversive prediction error signals in the amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9024-33 |
Barkus C, Line SJ, Huber A, et al. (2014) Variation in serotonin transporter expression modulates fear-evoked hemodynamic responses and theta-frequency neuronal oscillations in the amygdala. Biological Psychiatry. 75: 901-8 |
Baudonnat M, Huber A, David V, et al. (2013) Heads for learning, tails for memory: reward, reinforcement and a role of dopamine in determining behavioral relevance across multiple timescales. Frontiers in Neuroscience. 7: 175 |
Tunbridge EM, Huber A, Farrell SM, et al. (2012) The role of catechol-O-methyltransferase in reward processing and addiction. Cns & Neurological Disorders Drug Targets. 11: 306-23 |
McCabe C, Huber A, Harmer CJ, et al. (2011) The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology. 217: 271-8 |
Shippenberg TS, Bals-Kubik R, Huber A, et al. (1991) Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology. 103: 209-14 |